Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP)

Archives of Internal Medicine

Volumn 167, Issue 11, 2007, Pages 1122-1129

  McCullough, Peter A ^a   Jurkovitz, Claudine T ^b   Pergola, Pablo E ^c   McGill, Janet B ^d   Brown, Wendy W ^e   Collins, Alan J ^f   Chen, Shu Cheng ^f   Li, Suying ^f   Singh, Ajay ^g   Norris, Keith C ^h   Klag, Michael J ⁱ   Bakris, George L ^j  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

^f USRDS Coordinating Center   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK; SCREENING; SELF REPORT; STROKE; SURVIVAL; SURVIVAL RATE;

ALBUMINURIA; ANEMIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK ASSESSMENT; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS; UNITED STATES;

EID: 34250373302     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.11.1122     Document Type: Article

References (32)

1. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl. 2005;(98):S7-S10.
2. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey [published correction appears in Am J Kidney Dis. 2000;35:178]. Am J Kidney Dis. 1998;32:992-999.
3. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629-636.
4. National Kidney Foundation. Kidney disease outcomes quality initiative guideline. Am J Kidney Dis. 2002;39(suppl):S32-S36.
5. Shulman NB, Ford CE, Hall WD, et al; Hypertension Detection and Follow-up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension. 1989;13(5)(suppl):I80-I93.
6. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997;28:557-563.
7. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56:2214-2219.
8. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
9. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: National Diabetes Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:349-368. NIH publication 95-1468.
10. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med. 1989;111:788-796.
11. Klein R, Klein BE, Moss SE. The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med. 1991;151:1344-1348.
12. Klein R, Klein BE, Moss SE. Incidence of proteinuria in older-onset diabetes: a population perspective. Diabetes. 1993;42:381-389.
13. Klein R, Klein BE, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care. 1993;16:1325-1330.
14. Larkins RG, Dunlop ME. The link between hyperglycaemia and diabetic nephropathy [published correction appears in Diabetologia. 1992;35:1100]. Diabetologia. 1992;35:499-504.
15. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-1165.
16. Chobanian AV, Bakris GL, Black HR; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572.
17. Yerkey MW, Kernis SJ, Franklin BA, Sandberg KR, McCullough PA. Renal dysfunction and acceleration of coronary disease. Heart. 2004;90:961-966.
18. McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003;41:725-728.
19. McCullough PA. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens. 2004;13:591-600.
20. Soman SS, Sandberg KR, Borzak S, Hudson MP, Yee J, McCullough PA. The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest. 2002;122:669-677.
21. McCullough PA, Sandberg KR. Chronic kidney disease and sudden death: strategies for prevention. Blood Purif. 2004;22:136-142.
22. McCullough PA, Lepor NE. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. Rev Cardiovasc Med. 2005;6(suppl 3):S4-S12.
23. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42:22-35.
24. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
25. World Health Organization. WHO global infobase online. www.who.int/ncd_surveillance/infobase/web/InfoBasePolicyMaker/reports/ reportViewer.aspx?UN_Code=840&rptCode=BCP&dm=5. Accessed June 7, 2006.
26. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
27. Howard BV, Best LG, Galloway JM, et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006;29:391-397.
28. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in coronary care unit patients. J Am Coll Cardiol. 2000;36:679-684.
29. Haugen E, Nath KA. The involvement of oxidative stress in the progression of renal injury. Blood Purif. 1999;17:58-65.
30. Bakker SJ, Gansevoort RT, Stuveling EM, Gans RO, de Zeeuw D. Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? Curr Hypertens Rep. 2005;7:379-384.
31. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2006;290:H17-H29.
32. de Jong PE, Gansevoort RT. Screening techniques for detecting chronic kidney disease. Curr Opin Nephrol Hypertens. 2005;14:567-572.